Physiology AJP: Endocrinology and Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


News Physiol Sci 15: 192-195, 2000;
1548-9213/00 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (12)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lipton, J. M.
Right arrow Articles by Ichiyama, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lipton, J. M.
Right arrow Articles by Ichiyama, T.
News in Physiological Sciences, Vol. 15, No. 4, 192-195, August 2000
© 2000 Int. Union Physiol. Sci./Am. Physiol. Soc.

Marshaling the Anti-Inflammatory Influence of the Neuroimmunomodulator {alpha}-MSH

J. M. Lipton, A. Catania and T. Ichiyama

J. M. Lipton was previously in the Department of Physiology, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd., Dallas, Texas 75235-9040 and is now Chief Scientific Officer of ZENGEN, Inc., Woodland, California; A. Catania is in the Neuroimmunomodulation Laboratory, IRCCS Ospedale Maggiore, Milan, Italy 20122; and T. Ichiyama is at the Yamaguchi University School of Medicine, Ube, Yamaguchi 755-8505, Japan.
Inflammation in peripheral tissues should benefit from a novel focus on descending neuroimmunomodulatory anti-inflammatory influences stemming from CNS receptors for the peptide {alpha}-MSH. Because activation of glial and peripheral cell receptors modulates inflammatory activity, {alpha}-MSH peptides may aid treatment of a variety of CNS and peripheral inflammatory disorders. Activation of melanocortin receptors should thus promote control of inflammatory diseases.




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
L. Kang, K. W. McIntyre, K. M. Gillooly, Y. Yang, J. Haycock, S. Roberts, A. Khanna, T. F. Herpin, G. Yu, X. Wu, et al.
A selective small molecule agonist of the melanocortin-1 receptor inhibits lipopolysaccharide-induced cytokine accumulation and leukocyte infiltration in mice
J. Leukoc. Biol., October 1, 2006; 80(4): 897 - 904.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. W. Lam, S. J. Getting, and M. Perretti
In Vitro and In Vivo Induction of Heme Oxygenase 1 in Mouse Macrophages following Melanocortin Receptor Activation
J. Immunol., February 15, 2005; 174(4): 2297 - 2304.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
A. Catania, S. Gatti, G. Colombo, and J. M. Lipton
Targeting Melanocortin Receptors as a Novel Strategy to Control Inflammation
Pharmacol. Rev., March 1, 2004; 56(1): 1 - 29.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online